Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionMeyer Handelman Co
Latest Disclosed Ownership335,549 shares
Latest Disclosed Value $ 46,765,464
Meyer Handelman Co reports 0.35% decrease in ownership of GILD / Gilead Sciences, Inc.

On April 20, 2026 - Meyer Handelman Co filed a 13F-HR form disclosing ownership of 335,549 shares of Gilead Sciences, Inc. (US:GILD) valued at $46,765,464 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 336,724 shares of Gilead Sciences, Inc.. This represents a change in shares of -0.35% during the quarter. The current value of the position is $43,282,466 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-20 2026-03-31 13F GILEAD SCIENCES COM 375558103 335,549 -1,175 -0.35 46,765 13.15 1.0620
2026-01-15 2025-12-31 13F GILEAD SCIENCES COM 375558103 336,724 -10,645 -3.06 41,330 7.19 1.2941
2025-10-16 2025-09-30 13F GILEAD SCIENCES COM 375558103 347,369 -9,250 -2.59 38,558 -2.48 1.2192
2025-07-16 2025-06-30 13F GILEAD SCIENCES COM 375558103 356,619 -8,905 -2.44 39,538 -3.46 1.3040
2025-04-08 2025-03-31 13F GILEAD SCIENCES COM 375558103 365,524 -3,655 -0.99 40,957 20.10 1.4272
2025-01-14 2024-12-31 13F GILEAD SCIENCES COM 375558103 369,179 -1,705 -0.46 34,101 9.67 1.1800
2024-10-10 2024-09-30 13F GILEAD SCIENCES COM 375558103 370,884 -12,485 -3.26 31,095 18.22 1.0513
2024-07-16 2024-06-30 13F GILEAD SCIENCES COM 375558103 383,369 -8,743 -2.23 26,303 -8.43 0.9261
2024-04-11 2024-03-31 13F GILEAD SCIENCES COM 375558103 392,112 613 0.16 28,722 -9.44 1.0071
2024-01-17 2023-12-31 13F GILEAD SCIENCES COM 375558103 391,499 -855 -0.22 31,715 7.86 1.2348
2023-11-06 2023-09-30 13F Gilead Sciences Common Stock 375558103 392,354 8,900 2.32 29,403 -0.50 1.1844
2023-07-21 2023-06-30 13F Gilead Sciences Common Stock 375558103 383,454 -10,470 -2.66 29,553 -9.58 1.1936
2023-04-11 2023-03-31 13F Gilead Sciences Common Stock 375558103 393,924 -29,950 -7.07 32,684 -10.18 1.3665
2023-02-02 2022-12-31 13F/A-3 Gilead Sciences Common Stock 375558103 423,874 -11,650 -2.67 36,390 35.44 1.5210
2023-02-02 2022-12-31 13F/A-2 Gilead Sciences Common Stock 375558103 423,874 -11,650 36,390 1.4970
2023-02-01 2022-12-31 13F/A-1 Gilead Sciences Common Stock 375558103 423,874 -11,650 36,390 1.4970
2023-01-25 2022-12-31 13F Gilead Sciences Common Stock 375558103 423,874 -11,650 36 1.4970
2022-10-04 2022-09-30 13F GILEAD SCIENCES COM 375558103 435,524 -650 -0.15 26,867 -0.34 1.2414
2022-07-15 2022-06-30 13F GILEAD SCIENCES COM 375558103 436,174 -250 -0.06 26,960 3.91 1.1562
2022-04-06 2022-03-31 13F GILEAD SCIENCES COM 375558103 436,424 -800 -0.18 25,945 -18.28 0.9949
2022-01-25 2021-12-31 13F GILEAD SCIENCES COM 375558103 437,224 13,800 3.26 31,747 7.34 1.1830
2021-11-01 2021-09-30 13F GILEAD SCIENCES COM 375558103 423,424 3,900 0.93 29,576 2.38 1.2135
2021-08-18 2021-06-30 13F GILEAD SCIENCES COM 375558103 419,524 11,000 2.69 28,888 9.41 1.1410
2021-05-03 2021-03-31 13F GILEAD SCIENCES COM 375558103 408,524 32,675 8.69 26,403 20.58 1.0934
2021-02-03 2020-12-31 13F GILEAD SCIENCES COM 375558103 375,849 17,600 4.91 21,897 -3.27 0.9899
2020-10-28 2020-09-30 13F GILEAD SCIENCES COM 375558103 358,249 1,950 0.55 22,638 -17.42 1.1519
2020-07-16 2020-06-30 13F GILEAD SCIENCES COM 375558103 356,299 1,300 0.37 27,414 3.29 1.4613
2020-04-22 2020-03-31 13F GILEAD SCIENCES COM 375558103 354,999 14,399 4.23 26,540 19.92 1.6290
2020-01-23 2019-12-31 13F GILEAD SCIENCES COM 375558103 340,600 1,910 0.56 22,132 3.10 1.0626
2019-10-07 2019-09-30 13F GILEAD SCIENCES COM 375558103 338,690 11,790 3.61 21,466 -2.80 1.0862
2019-07-23 2019-06-30 13F GILEAD SCIENCES COM 375558103 326,900 7,350 2.30 22,085 7.42 1.1312
2019-04-30 2019-03-31 13F GILEAD SCIENCES COM 375558103 319,550 5,100 1.62 20,560 4.53 1.0696
2019-02-05 2018-12-31 13F GILEAD SCIENCES COM 375558103 314,450 27,000 9.39 19,669 -11.38 1.1125
2018-11-06 2018-09-30 13F GILEAD SCIENCES COM 375558103 287,450 700 0.24 22,194 9.26 1.0837
2018-07-30 2018-06-30 13F GILEAD SCIENCES COM 375558103 286,750 -3,222 -1.11 20,313 -7.08 1.0411
2018-04-23 2018-03-31 13F GILEAD SCIENCES COM 375558103 289,972 1,600 0.55 21,861 5.82 1.1133
2018-02-07 2017-12-31 13F GILEAD SCIENCES COM 375558103 288,372 -120,412 -29.46 20,659 -37.62 0.9898
2017-10-25 2017-09-30 13F GILEAD SCIENCES COM 375558103 408,784 21,284 5.49 33,119 20.76 1.5138
2017-07-20 2017-06-30 13F GILEAD SCIENCES COM 375558103 387,500 6,600 1.73 27,426 6.01 1.1589
2017-04-26 2017-03-31 13F GILEAD SCIENCES COM 375558103 380,900 9,900 2.67 25,871 -2.62 1.1023
2017-02-02 2016-12-31 13F GILEAD SCIENCES COM 375558103 371,000 4,800 1.31 26,567 -8.31 1.1768
2016-11-03 2016-09-30 13F GILEAD SCIENCES COM 375558103 366,200 6,100 1.69 28,974 -3.55 1.3010
2016-07-21 2016-06-30 13F GILEAD SCIENCES INC COM COM 375558103 360,100 9,000 2.56 30,039 -6.86 1.3480
2016-05-25 2016-03-31 13F GILEAD SCIENCES INC COM COM 375558103 351,100 0 0.00 32,251 -9.22 1.4911
2016-02-25 2015-12-31 13F GILEAD SCIENCES INC COM COM 375558103 351,100 -1,500 -0.43 35,528 2.62 1.6819
2015-10-21 2015-09-30 13F GILEAD SCIENCES INC COM COM 375558103 352,600 0 0.00 34,622 -16.13 1.7546
2015-07-27 2015-06-30 13F GILEAD SCIENCES INC COM COM 375558103 352,600 0 0.00 41,282 19.31 1.8868
2015-04-27 2015-03-31 13F GILEAD SCIENCES INC COM COM 375558103 352,600 352,600 0.00 34,600 1.5655
2015-01-28 2014-12-31 13F GILEAD SCIENCES INC COM COM 375558103 0 -353,100 -100.00 0 -100.00
2014-11-24 2014-09-30 13F GILEAD SCIENCES INC COM COM 375558103 353,100 -22,000 -5.87 37,587 20.86 1.7444
2014-07-31 2014-06-30 13F GILEAD SCIENCES INC COM COM 375558103 375,100 1,700 0.46 31,100 17.54 1.4398
2014-04-24 2014-03-31 13F GILEAD SCIENCES INC COM COM 375558103 373,400 -3,000 -0.80 26,459 -6.40 1.2712
2014-02-20 2013-12-31 13F GILEAD SCIENCES INC COM COM 375558103 376,400 0 0.00 28,267 19.46 1.3698
2013-10-21 2013-09-30 13F GILEAD SCIENCES INC COM COM 375558103 376,400 -11,000 -2.84 23,663 19.14 1.2594
2013-07-24 2013-06-30 13F GILEAD SCIENCES INC COM COM 375558103 387,400 387,400 19,862 1.0915
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.